Dosages for vitamin B7, biotin

(aminosam, azgobion, b-97, bio t, bio t zinc, biocare, biodermatin, biofair, biogelat biotin, bio-h-tin, bio-h-tin vitamin h, biopreg-f, biosure, biotebal, biotin, biotin 0.2% fuso, biotin beta, biotin forte uni ph, biotin fuso, biotin hermes, biotin heumann, biotin hexal, biotin merz, biotin swanson, biotin-a, biotin-asmedic, biotin-biomed forte, biotine, biotine bayer, biotine bayer 0.5%, biotinol, biotin-ratiopharm, biotisan, chevivit biotin e, cosmetin, curatin, cutvit, deacura, diathynil, doctodermis, foetop, gabunat, gabunat forte, gelacet, hitrace biotin, hoof, h-vit, medobiotin, microvit extra biotin, microvit h, natubiotin, nebiotin, panabiotin, rombellin biotin, sukin, vita biotin, medebiotin fuerte)

🍽️ More information

The dosages below are from completed studies on humans or on clinical trials on humans. In general, they represent safe dosages for most people. Please be aware that there is often an exponentail effectiveness. Talking half the dosage may only see 1/4 of the effect. We are not looking at minimum effective dosage, but maximum [safe] dosage used in clinical trials and studies.

If a study has been completed, the dosage will be marked Ineffective or Effective -- depending if statistically changes were reported by the study.


This is not medical advice (see your MD for that). It is a reporting on dosages that some MDs have used.
Look up dosages for other substances

Suggestions for vitamin B7, biotin
Study Clinical Study Dosage Effective
πŸ“š Study . 10000   µg/day Effective
πŸ“š Study . 10   mg/kg/day Effective
πŸ“š Study . 300   mg/day Effective
. Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis 300   mg/day
πŸ“š Study MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study 300   mg/day Effective

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.